Cargando…

Case Report: Single Dose Anti-PD1 in a Patient With Metastatic Melanoma and Cardiac Allograft

BACKGROUND: Immune-checkpoint inhibition has improved outcomes in metastatic melanoma. However, limited data describes the safety and efficacy of this treatment in the setting of cardiac allograft. Emerging translational and clinical evidence suggests that the majority of the benefit from these ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Goodman, Amy E., Karapetyan, Lilit, Pugliano-Mauro, Melissa, Levenson, Joshua E., Luke, Jason J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019780/
https://www.ncbi.nlm.nih.gov/pubmed/33828564
http://dx.doi.org/10.3389/fimmu.2021.660795